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Abstract
Background: Melasma is a chronic acquired focal hypermelanosis affecting photoexposed areas, especially for
women during fertile age. Several factors contribute to its development: sun exposure, sex steroids, medicines, and
family history. Melanic pigmentation pathway discloses several SNPs in different populations. Here, we evaluated
the association between genetic ancestry and facial melasma.
Methods: A cross-sectional study involving women with melasma and an age-matched control group from
outpatients at FMB-Unesp, Botucatu-SP, Brazil was performed. DNA was extracted from oral mucosa swabs and
ancestry determined by studying 61 INDELs. The genetic ancestry components were adjusted by other known risk
factors by multiple logistic regression.
Results: We evaluated 119 women with facial melasma and 119 controls. Mean age was 39 ± 9 years. Mean age at
beginning of disease was 27 ± 8 years. Pregnancy (40%), sun exposure (37%), and hormonal oral contraception
(22%) were the most frequently reported melasma triggers. All subjects presented admixed ancestry, African and
European genetic contributions were significantly different between cases and controls (respectively 10% vs 6%;
77% vs 82%; p < 0.05). African ancestry (OR = 1.04; 95% CI 1.01 to 1.07), first generation family history (OR = 3.04; 95%
CI 1.56 to 5.94), low education level (OR = 4.04; 95% CI 1.56 to 5.94), and use of antidepressants by individuals with
affected family members (OR = 6.15; 95% CI 1.13 to 33.37) were associated with melasma, independently of other
known risk factors.
Conclusions: Facial melasma was independently associated with African ancestry in a highly admixed population.
Keywords: Melasma, Melanosis, Contraceptives, Oral contraceptives, Pregnancy, Hormones, Gonadal steroid
hormones, Melanosis, Pigmentation, Skin pigmentation, Ultraviolet rays, Pigmentation disorders, Ancestry, INDEL
Background
Melasma is an acquired chronic hypermelanosis
which mainly affects women during fertile age. Its
aetiology is not fully understood, however, many
factors can trigger or aggravate it: sun exposure, hor-
monal contraception (HC), hormone replacement
therapy, cosmetics, photosensitising medication,
pregnancy, and psychological stress. High levels of
occurrence in families (40–60%) suggest a genetic
component [1–3].
Ancestry-informative markers (AIMs) are used to esti-
mate ancestral contributions to individuals due to their
large allele frequency differences between geographically
or ethnically defined populations [4]. AIMs have not
been used to estimate the genetic contribution of popu-
lation ancestry in melasma. However, self-reported
Amerindian ancestry was linked to melasma in Brazil
[5]. Some authors have also identified polymorphisms
and different gene expression patterns related to skin
pigmentation which are associated with the population
origin [6–8].
The Brazilian population originated as a result of the
admixture process that took place mostly between three
ancestral groups, namely European colonisers, enslaved
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Africans and native Amerindians, which started more than
500 years ago [9–11]. This study aimed to evaluate genetic
ancestry in Brazilian patients with facial melasma.
Methods
A cross-sectional study was performed with women over
18 years-old under treatment at Botucatu University
Hospital – UNESP between November/2013 and May/
2014. The project was approved by the institutional
research ethics committee.
Cases were determined by the presence of facial mel-
asma, clinically confirmed by a dermatologist. Controls
were paired with cases according to age group (±5 years).
Subjects were not included if they had other facial derma-
toses, reported Asian descent, or extreme Fitzpatrick’s
phototypes I and VI (due to the absence of these extreme
phototypes in this sample of melasma patients).
Sampling was performed by convenience on consecutive
patients seen at the clinic. Subjects were interviewed by
the researcher using a semi-structured form, they then
rinsed their mouths with clean bottled mineral water and
a sample of oral mucosa was taken using a swab.
DNA was extracted using a QIAmp DNA micro kit in
a QIAcube and the QIAmp® DNA Investigator kit proto-
col provided by QIAGEN (USA) [12], in the Maternal
Fetal Laboratory – UNESP. The samples were amplified
and genotyped for 61 insertion-deletion (INDEL) AIMs
(Additional file 1: Table S1) valid for the Brazilian popu-
lation in the Human Genetics and Medicine Laboratory
(LGHM-UFPA) [13, 14].
Amplification was performed using a multiplex PCR
technique in a final volume of 10 μL (1 μL DNA + 1 μL
Primer mix + 5 μL Taq PCR Master Mix Qiagen + 1 μL
Qsolution + 2 μL water) [14]. The PCR product (1 μL)
was added to a mix containing 8.7 μL formamide and
0.3 μL Gene Scan 500 LIZ standard size ladder (Applied
Biosystems). The DNA fragments were genotyped by ca-
pillary electrophoresis using an automatic ABI PRISM®
3130 Genetic Sequencer Analyser (Applied Biosystems,
USA), and analysed with Gene Mapper® IDv3.2 (Applied
Biosystems). Allele identification was performed with
reference to the 500 LIZ standard size ladder (Applied
Biosystems) [14].
The ancestry of the Brazilian samples was estimated
using STRUCTURE v2.3.4, using three parental popula-
tions (Amazonian Amerind, Sub-Saharan African and
Western European). This assessment was based on a val-
idated database with 593 individuals of known ancestry
that resulted in 98% correct classification: Sub-Saharan
Africans - 189 individuals fromAngola, Mozambique,
Zaire, Cameroon, and the Ivory Coast; Europeans −161
individuals, mainly Portuguese; and Amerindians - 243
individuals from indigenous tribes of the Brazilian
Amazon region [14–17].
Categorical and ordinal data were shown as percent-
ages and compared between groups by the chi-squared
or chi squared for trend test. Continuous data were
represented by means and standard deviations or
medians and quartiles (p25–p75) according to the Shapiro-
Wilk test (normality), and compared by the Student t,
Mann-Whitney or Jonckheere-Terpstra tests [18, 19].
Correlations between ancestral components and other
continuous variables were estimated by Spearman’s coef-
ficient of correlation (rho) [18, 20].
Ancestry components were tabulated and percentages
from each group compared between cases and controls
or according to phototype or schooling by multivariate
analysis of variance (MANOVA-Pillai’s trace) with post-
hoc Bonferroni test. Ancestral components were normal-
ised with a log10 transformation (for the MANOVA test).
Homoscedasticity was evaluated with the Levene test [18].
In order to adjust the effect of ancestry for clinical and
other epidemiologic factors, a multivariate model (condi-
tional multiple logistic regression) was built. The covari-
ates were included according to their significance (p < 0.2)
at the bivariate analysis, but collinearities were supressed.
Interactions between final terms of the model were tested
for their additive effect. Effect size was estimated by odds
ratio (OR) and its 95% confidence interval [21, 22].
Missing data (<10%), for multivariate analysis, were es-
timated by multiple imputation using ten iterations [23].
Sensitivity analysis was performed by: evaluating the
final multivariate logistic regression model without
imputed data.
The sample size calculation was based on a pre-test
with 100 cases and 100 controls calculated for a final
multiple logistic regression model with 80% power and a
two-sided alpha level of 0.05. It resulted in 110 subjects
in each group, leading to an effect size (R2) of more than
0.3 [21, 22, 24].
Data were analysed with IBM-SPSS 20.0 [25]. Significance
was set at p < 0.05.
Results
We evaluated 119 women with facial melasma and a
similar number of controls (n = 238). Clinical character-
istics of patients with facial melasma are shown in
Table 1. The onset of melasma was during fertile age;
pregnancy and sun exposure were the most prevalent
triggering factors; and centrofacial topography was the
most affected area. No melasma patient had skin photo-
type I or VI. Pregnancy occurred in 92 (77%) cases, and
pregnancy-induced melasma was reported by 48 (52%)
patients who had become pregnant.
Main demographic and genetic ancestry data for the
groups are shown in Table 2. There is a higher frequency
of first generation family report of melasma, history of
pregnancy, daily sun exposure, low schooling level and
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African ancestry among cases. All subjects presented
mixed genetic ancestry. European ancestry was predomin-
ant in both groups followed by African and Amerindian
components.
Figure 1 shows case and control distribution related to
genetic ancestry. There was a significant difference be-
tween groups for ancestral components with significant
variation for African and European ancestry.
Multivariate analysis (Table 2) showed that the follow-
ing were independently significant for melasma develop-
ment: low education level, family history of melasma
and African ancestry. Significant interaction was seen
between use of antidepressants and family history of
melasma (OR = 6.15; 95% CI 1.13 to 33.37; p < 0.01).
Sensitivity analysis using logistic regression without
imputed data (n = 180) provided a similar result to the
complete model (Additional file 2: Table S2).
Subjects with higher education levels exhibited higher
median European ancestry and lower Amerindian ances-
try than those with lower education levels, without dif-
ference between cases and controls (p > 0.1). Estimated
ancestral contributions according to college, high school
and elementary education were for European: 84, 79 and
76% (p < 0.01); for African: 5, 9 and 11% (p < 0.01); and
for Amerindian: 6, 7, 9% (p = 0.01).
There was moderate correlation between European
(rho = −0.43; p < 0.01) and African (rho = 0.41; p < 0.01)
ancestry component and phototypes, but poor correl-
ation with phototype for the Amerindian ancestral com-
ponent (rho = 0.18; p < 0.01) (Additional file 3: Table S3).
Among melasma patients, genetic ancestry did not
show an association with reported triggering factors,
family history, or age at disease onset. The number of
affected facial topographies decreased in proportion to
education level: mean 4.0, 3.4 and 2.4 lesions (Additional
file 4: Table S4) among participants with elementary, high
school and college education (p < 0.01). Similarly, it was
weakly correlated with the European ancestral component
(rho = −0.23; p = 0.01), but not with the African and
Amerindian components (rho = 0.18 and 0.15; p > 0.05).
Discussion
African genetic ancestry, as well as education and family
history are associated with the development of female fa-
cial melasma in a highly genetically admixed population,
independently of skin phototype and other risk factors.
Melasma patients in this study presented phenotype,
clinical, and demographic characteristics similar to other
Brazilian studies: disease onset during fertile age (16 to
35 years); the main triggers being sun exposure and
hormones (pregnancy and HC), preferentially affecting
the centrofacial region, high occurrence in family
members and greater prevalence among dark photo-
types (III to V) [3, 26].
Ancestral origin can be associated with diverse im-
munological responses patterns, metabolic processes, host
response to infections, and drug treatment outcomes
which justify clinical studies investigating ancestral com-
ponents in admixed populations [27–31]. Amerindian an-
cestry is associated with a lower risk of leprosy [32] as well
as for Alzheimer’s disease [33], but a higher risk of sys-
temic lupus erythematous [34, 35]. European ancestry is
associated with higher risk of neuromyelitis optica and
multiple sclerosis, [36] sleep apnoea, [37] and death from
heart failure [38]. Obesity shares African origin genes, [39]
as do asthma and IgE level [40].
Brazil, especially the studied region, has experienced
considerable admixture between Amerindian, European
and African populations [41]. Skin pigmentation exhibits
polygenic inheritance and several single nucleotide
polymorphisms were identified in pigmentation genes in
different ancestral groups [6–8, 42].
Despite the high admixture rate, European ancestry
is the most prominent among the Brazilian popula-
tion, as shown in our sample [11]. Physical traits and
parental reports can lead to a mismatch between self-
reported and genetic ancestry, which may explain the
lack of association observed in our study between
Amerindian ancestry and melasma, even though a
Table 1 Clinical and demographic data for patients with
melasma
Age of melasma onset (years)a 27.2 (8.3)
Reported trigger factor − N (%)
Pregnancy 48 (40)




Stressful events 3 (3)
Others 6 (5)
Affected facial site − N (%)
Zygomatic 60 (50)
Frontal 48 (40)







Affected facial sitesb 3 (2–4)
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Bivariate analysis Multivariate analysis
Odds Ratio (CI 95%) p Odds Ratio (CI 95%) p
Age (years)a 39.0 (8.2) 39.0 (9.7) – – 0.99 (0.95–1.02) 0.44
Skin phototype-N (%) 0.09 0.13
II 18 (15) 30 (25) 1.00 (–) 1.00 (–)
III 42 (35) 45 (38) 1.56 (0.76–3.20) 1.32 (0.57–3.02)
IV 46 (39) 30 (25) 2.56 (1.22–5.38) 1.40 (0.58–3.39)
V 13 (11) 14 (12) 1.55 (0.60–4.02) 0.39 (0.11–1.40)
Education level-N (%) <0.01 0.01
Elementary-Middle school 39 (33) 14 (12) 4.67 (2.24–9.73) 4.04 (1.62–10.11)
High school 43 (36) 43 (36) 1.68 (0.93–3.01) 1.71 (0.85–3.44)
College 37 (31) 62 (52) 1.00 (–) 1.00 (–)
Family with melasma (first degree)-N (%) 67 (56) 27 (24) 3.10 (1.11–8.70) 0.03 3.04 (1.56–5.94) <0.01
Age of menarche (years)a 12.8 (1.8) 12.7 (1.8) 1.01 (0.88–1.16) 0.92 – –
Time using hormonal contraception (years)b 10 (3–15) 5 (1–12) 1.03 (0.98–1.07) 0.13 1.02 (0.98–1.07) 0.33
Daily regular sun exposition-N (%) 42 (44) 24 (27) 2.15 (1.16–3.99) 0.02 1.09 (0.57–2.10) 0.80
Pregnancy history-N (%) 92 (77) 77 (65) 1.86 (1.05–3.29) 0.03 1.50 (0.69–3.29) 0.31
Psycotropic drugs (regular use)-N (%)
Antidepressant 28 (24) 18 (15) 1.73 (0.90–3.33) 0.10 2.96 (0.37–24.03) 0.31
Anxiolytic 11 (9) 5 (4) 2.32 (0.78–6.90) 0.12 – –
Genetic ancestry (%)b
European component 77 (64–89) 82 (69–90) 0.98 (0.97–0.99) 0.04 – –
Amerindian component 7 (4–14) 7 (4–14) 1.00 (0.97–1.02) 0.72 – –
African component 10 (4–21) 6 (4–16) 1.03 (1.01–1.05) <0.01 1.04 (1.01–1.07) <0.01
Interactions
Antidepressanta Family with melasma 6.15 (1.13–33.37) <0.01
Antidepressanta Pregnancy history 0.14 (0.01–1.35) 0.09
p (overall model) < 0.01; Hosmer-Lemeshow test: p = 0.98; Correct classification: 72%; R2 (Nagelkerke): 0.31
amean (st deviation)
bmedian (p25–p75)
Fig. 1 Ternary plot of group genetic ancestral composition
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positive association was described earlier in the same
population [5, 43].
Melasma is less prevalent in Europeans, and more fre-
quent in Asians and Latin Americans, who have a com-
mon phylogenetic origin in human migrations from
Africa [44, 45]. In a study of genetic ancestry of the
skin pigment system, similarities were seen between
European and Asian expression patterns which differed
from the African pattern. The authors also showed
that pigmentation is the result of complex cellular in-
teractions in which a large contingent of genes and
regulatory factors are not completely understood, such as
NINL, S100A4, H19, WIF-1, PDZK1, sex steroids, and
miRNA-675 [46–52].
Furthermore, melanogenesis in melasma presents a
different pathophysiological pattern than common tan-
ning, ephelides and solar lentigines. A study on long
wavelength UVA and visible light (violet and blue) identi-
fied a delayed pigmentation similar to melasma, and it was
not identified among lighter phototypes [53–55]. The
evolutive gain of melanogenesis promoted by non-ionizing
radiation in darker skin is still not understood, but can sup-
port the relapsing of melasma despite adequate UVB and
short wavelength UVA photoprotection [56].
There are histopathological similarities found in skin
with melasma and dark skin. African skin has large non-
aggregated melanosomes distributed through all layers
of the epidermis with an increased number in the basal
layer [57, 58]. The stratum corneum from black skin has
less lipids and the dermis has the same thickness as
Caucasian skin, however fibroblasts and macrophages
are larger, more numerous, and hyperactive [57, 59, 60].
In an analogous way, the histopathological characteris-
tics of highly pigmented skin, such as more mature me-
lanosomes, greater dermic cellularity and reduced lipid
layer are also present in patients with melasma. More-
over, after sun exposure, skin with melasma develops a
more intense pigmentation than adjacent skin, as a lo-
calized darker phenotype [2, 61–64].
There was no information on melasma prevalence ac-
cording to social strata or income levels. This is the first
study to explore its prevalence across educational levels.
Lower education is associated with lower socioeconomic
status, higher overall mortality, less information regarding
disease prevention, and less concern with personal health.
Social and educational status can be considered as a proxy
indicator for these factors that can be a confounding in
the association with melasma and ancestry [65]. Patients
with melasma and low schooling level could be less adept
at sun protection, probably due to the lack of information
on prevention and the cost of sunscreen products. They
can be more exposed to the sun in the course of their
daily life, as they work in jobs which require less instruc-
tion but more exposure to UVR.
Our study also showed that the number of facial top-
ographies affected by the disease is lower in relation to
education level. Also, schooling is associated with lower
African and Amerindian ancestral components, in con-
trast with European ancestry. However, low educational
level and African ancestry were independently associated
with melasma. In addition to educational level, further
studies need to evaluate the association between family
income and melasma and its severity.
Observational studies are subject to memory and in-
formation bias, which in this case could have occurred
in family history, use of medication and daily sun expos-
ure. It is believed that there were similar imprecision
levels between cases and controls which minimises their
impact in final results.
Generalisation of this study is difficulted due to the fact
that cases and controls were recruited from a public der-
matologic service in the interior of Brazil, however, group
homogeneity in relation to patient geographic and social
origin, guarantees comparability between them. Similarly,
the exclusion of Asian individuals and extreme phototypes
(I & VI)-specifically associated with European and African
ancestry, maximised the exploration of cases and controls
with a higher genetic admixture, strengthening the in-
ternal validity of our results.
This investigation must be further pursued in patients
with extrafacial melasma, men, and other populations
with different genetic ancestral components, such as
Middle Eastern, East Asian and populations from Oceania.
Additionally an exploratory study on the mosaicism of the
pigmentary system, especially in genes reported as related
to ancestry, is warranted.
Conclusions
Facial melasma was independently associated with African
ancestry in a highly admixed population.
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